Kanaph Therapeutics

Developing next generation therapeutics for oncology and autoimmune diseases.

Launch date

2019

Employees

Market cap

Net debt

-

Enterprise valuation

Company register number 6438701092

South Korea (HQ)

http://www.kanaphtx.com

https://www.linkedin.com/company/kanaph/

Get premium to view all results

Date	Investors	Amount	Round
-	investor	$0.0	round
Mar 2019	N/A	$0.0	round
Oct 2019	investor investor	$0.0	round
Oct 2020	investor investor investor	$0.0	round
Dec 2023	N/A	$23.8m	Series B
Total Funding		000k